The Latest in CF ResearchToday, we announced three new research awards as part of our Path to a Cure initiative to accelerate the development of treatments for the underlying cause of cystic fibrosis for every person with the disease. This includes up to $2.6 million to Eloxx Pharmaceuticals to identify compounds that could potentially treat individuals who have nonsense mutations, as well as awards to Hunterian Medicine and Metagenomi to advance genetic therapies for all people wth CF. Read the announcement »
| |
Do You Have an Emergency and Disaster Plan?
| |
Design Swag for BreatheCon 2021
| |
The 65 Roses Story
The 65 Roses story dates back to 1965, but do you know the history behind the term? As we get ready for 65 Roses Day on June 5, learn why children of all ages use the term "65 Roses" to describe cystic fibrosis. Get to know the 65 Roses story »
| |
|
|
|
|